On our 1 year anniversary of launching DNKO, we received our first grant of $50k to support our preclinical LITT + LTSL-Dox study which will begin in August 2024 with our Dartmouth School of Medicine collaborators. 

Our next milestone is to raise $2.27M for supplementary preclinical studies as needed and a Phase I in recurrent GBM patients.